BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:VIC-1911 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of VIC-1911\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07350057-2194@assetmemo.bio
DTSTAMP:20261121T010125Z
DTSTART;VALUE=DATE:20270131
DTEND;VALUE=DATE:20270201
SUMMARY:VIC-1911: Phase 1 readout est. (NCT07350057)
DESCRIPTION:VIC-1911\, phase 1.\nStudy: A Preliminary Clinical Study on the
  Efficacy of Cyclophosphamide and Sirolimus Combined With VIC-1911 in Prev
 enting Graft-versus-Host Disease After Haploidentical Stem Cell Transplant
 ation in Children\nEstimated primary completion: 31 January 2027. This is 
 a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can 
 move.\nDrug page: https://assetmemo.bio/drug/vic-1911#upcoming-events\nReg
 istry record: https://clinicaltrials.gov/study/NCT07350057
URL:https://assetmemo.bio/drug/vic-1911#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
